Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neuroprotective Drugs”

52 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 52 results

Testing effectiveness (Phase 2)Study completedNCT05585606
What this trial is testing

Study of the Safety and Neuroprotective Capacity of Scp776 in Acute Ischemic Stroke

Who this might be right for
Acute Ischemic Stroke (AIS)
Silver Creek Pharmaceuticals 120
Testing effectiveness (Phase 2)Study completedNCT03161028
What this trial is testing

Lipoic Acid for Progressive Multiple Sclerosis (MS)

Who this might be right for
Multiple Sclerosis
VA Office of Research and Development 115
Testing effectiveness (Phase 2)Study completedNCT01854294
What this trial is testing

GM604 Phase 2A Randomized Double-blind Placebo Controlled Pilot Trial in Amyotrophic Lateral Disease (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Genervon Biopharmaceuticals, LLC 12
Large-scale testing (Phase 3)Study completedNCT01726075
What this trial is testing

Trial to Assess the Efficacy of Neuroprotective Drugs Administered Topically to Prevent or Arrest Diabetic Retinopathy

Who this might be right for
Diabetic Retinopathy
BCN Peptides 450
Testing effectiveness (Phase 2)Study completedNCT00753636
What this trial is testing

Parkinson's Disease Isradipine Safety Study

Who this might be right for
Parkinson's Disease
Northwestern University 31
Testing effectiveness (Phase 2)Study completedNCT00630396
What this trial is testing

Study of a Neuroprotective Drug to Limit the Extent of Damage From an Ischemic Stroke

Who this might be right for
Stroke, Acute
David Hess, MD 60
Testing effectiveness (Phase 2)Study completedNCT01910259
What this trial is testing

MS-SMART: Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial

Who this might be right for
Secondary Progressive Multiple Sclerosis
University College, London 445
Not applicableEnded earlyNCT01486459
What this trial is testing

A Feasibility Trial Using Lithium As A Neuroprotective Agent In Patients Undergoing Prophylactic Cranial Irradiation For Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
Barwon Health 7
Testing effectiveness (Phase 2)Ended earlyNCT01502761
What this trial is testing

Intra-arterial Magnesium Administration for Acute Stroke

Who this might be right for
Acute Stroke
University of Southern California 4
Not applicableStudy completedNCT05297851
What this trial is testing

Cytoflavin in Combination With Reperfusion in Stroke Patients

Who this might be right for
Acute Stroke
POLYSAN Scientific & Technological Pharmaceutical Company 200
Testing effectiveness (Phase 2)Study completedNCT01553916
What this trial is testing

Neuroprotective Effects of Lithium in Patients With Small Cell Lung Cancer Undergoing Radiation Therapy to the Brain

Who this might be right for
Small Cell Lung Carcinoma
Washington University School of Medicine 19
Large-scale testing (Phase 3)Looking for participantsNCT07167550
What this trial is testing

The Study of Efficacy and Safety of Dimephosphon® in Acute Ischemic Stroke

Who this might be right for
StrokeAcute StrokeIschemic Stroke+2 more
Tatchempharmpreparaty, JSC 184
Not applicableNot Yet RecruitingNCT07260760
What this trial is testing

Clinical Comprehensive Evaluation of Neuroprotective Drugs for Acute Ischemic Stroke

Who this might be right for
Acute Ischemic Stroke
Qianfoshan Hospital 600
Testing effectiveness (Phase 2)Study completedNCT00013585
What this trial is testing

Safety and Effectiveness of the Selegiline "Patch" for Decreased Mental Function in HIV Patients

Who this might be right for
Cognition DisordersHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 127
Large-scale testing (Phase 3)UnknownNCT05124353
What this trial is testing

Early Administration of Cerebrolysin on the Outcome of Patients With Acute Stroke Undergoing EVT

Who this might be right for
Stroke, Acute, Ischemic
Pomeranian Medical University Szczecin 100
Large-scale testing (Phase 3)Study completedNCT01388738
What this trial is testing

Navigation Brain Stimulation for Evaluation of the Neuroprotective Drug Efficiency in Patients After Ischemic Stroke.

Who this might be right for
Stroke
Clinical Institute of the Brain, Russia 30
Early research (Phase 1)Study completedNCT01064505
What this trial is testing

Safety Study of a Single IVT Injection of QPI-1007 in Chronic Optic Nerve Atrophy and Recent Onset NAION Patients

Who this might be right for
Optic AtrophyNon-arteritic Anterior Ischemic Optic Neuropathy
Quark Pharmaceuticals 48
Large-scale testing (Phase 3)Study completedNCT01188811
What this trial is testing

Lipoic Acid for Secondary Progressive Multiple Sclerosis (MS)

Who this might be right for
Multiple Sclerosis, Chronic Progressive
VA Office of Research and Development 54
Not applicableEnded earlyNCT01502748
What this trial is testing

Endovascular Magnesium Sampling in Acute Stroke

Who this might be right for
Acute Stroke
University of Southern California 2
Not applicableStudy completedNCT00027040
What this trial is testing

Decreased Mental Function Associated With HIV

Who this might be right for
Cognitive DisordersHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 90
Load More Results